Forward Citations = 0

Loading Chart...

17 inventors (with patents filed for the assignee):

Ming-Hsi Chuang (3 out of 14 patents)

Chia-Hsin Lee (3 out of 4 patents)

Kai-Ling Zhang (2 out of 4 patents)

4. PO-Cheng Lin (2 out of 2 patents)

5. Po-Cheng Lin (1 out of 11 patents)

6. Zih-Han Hong (1 out of 2 patents)

7. Wei Wu Li (1 out of 1 patent)

8. Shinn-Zong Lin (1 out of 1 patent)

9. Chun-hung Chen (1 out of 2 patents)

10. Pi-chun Huang (1 out of 1 patent)

11. Ruei-Yue Liang (1 out of 2 patents)

12. Yi-Chun Lin (1 out of 1 patent)

13. Chao-Liang Chang (1 out of 1 patent)

14. Tzyy-Wen Chiou (1 out of 1 patent)

15. Mao-Hsuan Huang (1 out of 1 patent)

3 patents: Sort by Forward Citations

1. 12661376 - OPTIMIZED CELL TRANSPLANT, AND PREPARATION METHOD AND USE THEREOF (2026-06-23),

2. 12649902 - High-expression type mesenchymal stem cells, culture method and use thereof (2026-06-09),

3. 12594304 - Method for treating liver cirrhosis by using composition comprising mesenchymal stem cell. extracellular vesicle produced by mesenchymal stem cell, and growth factor (2026-04-07),

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

3 Patents

#574 in Hsinchu County

#3,309 in Taiwan

Hsinchu County, Taiwan

Gwo XI Stem Cell Applied Technology Co., Ltd.

Forward Citations = 0

17 inventors:

Ming-Hsi Chuang (3 out of 14 patents)

Chia-Hsin Lee (3 out of 4 patents)

Kai-Ling Zhang (2 out of 4 patents)

4. PO-Cheng Lin (2 out of 2 patents)

5. Po-Cheng Lin (1 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Gwo XI Stem Cell Applied Technology Co., Ltd.. Retrieved from https://idiyas.com/company/gwo-xi-stem-cell-applied-technology

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]